Trial Profile
Action in Diabetes and Vascular disease: preterAx and diamicroN-mr Controlled Evaluation
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2006
Price :
$35
*
At a glance
- Drugs Perindopril/indapamide (Primary) ; Antihyperglycaemics; Antihypertensives; Gliclazide
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms ADEPT
- 29 Nov 2006 New trial record.